首页> 外文期刊>Precision Clinical Medicine >Gut microbiota metabolite regulation of host defenses at mucosal surfaces: implication in precision medicine
【24h】

Gut microbiota metabolite regulation of host defenses at mucosal surfaces: implication in precision medicine

机译:肠道微生物群在粘膜表面防御系统的代谢物调控:对精密医学的启示

获取原文
       

摘要

The gut microbiota has a well-established role in the regulation of host homeostasis. Multiple factors control the composition and function of the microbiota. The westernization of diet, a shift away from nutrient-dense foods toward diets high in saturated fats, has been implicated in the rise of chronic inflammatory diseases such as inflammatory bowel disease (IBD). Diet is critical in the development and maintenance of a healthy microbiome, where dietary fiber (found in the highest amounts in fruits, vegetables, and legumes) is metabolized by the microbiome. In turn, the bacterial metabolites of dietary fiber, short chain fatty acids (SCFAs), regulate gut homeostasis. SCFAs engage G-protein coupled receptors (GPRs) and act as histone deacetylase inhibitors (HDACi) to module epithelial and immune cell functions in the intestines, where they generally promote an anti-inflammatory state. This review highlights the functions of SCFAs and their roles in the pathogenesis of IBD to provide insights into their potential therapeutic application for the treatment of IBD for the purposes of precision medicine.
机译:肠道菌群在调节宿主体内稳态中具有公认的作用。多种因素控制着微生物群的组成和功能。饮食的西方化已从营养丰富的食物向富含饱和脂肪的食物转变,这与诸如炎症性肠病(IBD)的慢性炎症性疾病的发展有关。饮食对于健康的微生物组的发展和维持至关重要,在微生物组中,膳食纤维(在水果,蔬菜和豆类中含量最高)被膳食纤维代谢。反过来,膳食纤维的细菌代谢产物,短链脂肪酸(SCFA)则调节肠道稳态。 SCFA与G蛋白偶联受体(GPR)结合,并作为组蛋白脱乙酰基酶抑制剂(HDACi)来调节肠道中上皮和免疫细胞的功能,它们通常会促进抗炎状态。这篇综述着重介绍了SCFA的功能及其在IBD发病机理中的作用,以深入了解其在精密医学方面治疗IBD的潜在治疗应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号